BioCentury
ARTICLE | Company News

Genzyme Molecular licenses p53 rights to Affymetrix

June 29, 2000 7:00 AM UTC

Genzyme Molecular Oncology (GZMO) granted AFFX an exclusive license to certain high density DNA array diagnostic and research rights related to the p53 tumor suppressor gene. The license will allow AF...